1. Home
  2. CUE vs LIVE Comparison

CUE vs LIVE Comparison

Compare CUE & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • LIVE
  • Stock Information
  • Founded
  • CUE 2014
  • LIVE 1968
  • Country
  • CUE United States
  • LIVE United States
  • Employees
  • CUE N/A
  • LIVE 1770
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • LIVE Other Specialty Stores
  • Sector
  • CUE Health Care
  • LIVE Consumer Discretionary
  • Exchange
  • CUE Nasdaq
  • LIVE Nasdaq
  • Market Cap
  • CUE 59.5M
  • LIVE 54.1M
  • IPO Year
  • CUE 2018
  • LIVE N/A
  • Fundamental
  • Price
  • CUE $0.74
  • LIVE $17.86
  • Analyst Decision
  • CUE Strong Buy
  • LIVE
  • Analyst Count
  • CUE 2
  • LIVE 0
  • Target Price
  • CUE $3.00
  • LIVE N/A
  • AVG Volume (30 Days)
  • CUE 116.9K
  • LIVE 23.2K
  • Earning Date
  • CUE 08-12-2025
  • LIVE 08-07-2025
  • Dividend Yield
  • CUE N/A
  • LIVE N/A
  • EPS Growth
  • CUE N/A
  • LIVE N/A
  • EPS
  • CUE N/A
  • LIVE 0.46
  • Revenue
  • CUE $8,286,000.00
  • LIVE $443,794,000.00
  • Revenue This Year
  • CUE N/A
  • LIVE N/A
  • Revenue Next Year
  • CUE $10.19
  • LIVE N/A
  • P/E Ratio
  • CUE N/A
  • LIVE $35.61
  • Revenue Growth
  • CUE N/A
  • LIVE N/A
  • 52 Week Low
  • CUE $0.45
  • LIVE $6.25
  • 52 Week High
  • CUE $1.99
  • LIVE $25.88
  • Technical
  • Relative Strength Index (RSI)
  • CUE 38.09
  • LIVE 52.19
  • Support Level
  • CUE $0.77
  • LIVE $14.99
  • Resistance Level
  • CUE $0.79
  • LIVE $23.00
  • Average True Range (ATR)
  • CUE 0.04
  • LIVE 1.76
  • MACD
  • CUE -0.01
  • LIVE -0.24
  • Stochastic Oscillator
  • CUE 12.87
  • LIVE 35.80

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

Share on Social Networks: